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Background-—Invasive measures of microvascular resistance in the culprit coronary artery have potential for risk stratiﬁcation in
acute ST-segment–elevation myocardial infarction. We aimed to investigate the pathological and prognostic signiﬁcance of
coronary thermodilution waveforms using a diagnostic guidewire.
Methods and Results-—Coronary thermodilution was measured at the end of percutaneous coronary intervention, (PCI) and contrast-
enhanced cardiacmagnetic resonance imaging (MRI) was intended onday 2 and 6 months later to assess left ventricular (LV) function and
pathology. All-cause death or ﬁrst heart failure hospitalization was a pre-speciﬁed outcome (median follow-up duration 1469 days).
Thermodilution recordings underwent core laboratory assessment. A total of 278 patients with acute ST-segment elevation myocardial
infarction EMI (72% male, 5911 years) had coronary thermodilution measurements classiﬁed as narrow unimodal (n=143 [51%]), wide
unimodal (n=100 [36%]), or bimodal (n=35 [13%]). Microvascular obstruction and myocardial hemorrhage were associated with the
thermodilution waveform pattern (P=0.007 and 0.011, respectively), and both pathologies were more prevalent in patients with a bimodal
morphology. On multivariate analysis with baseline characteristics, thermodilution waveform status was a multivariable associate of
microvascular obstruction (odds ratio [95% conﬁdence interval]=5.29 [1.73, 16.22];, P=0.004) and myocardial hemorrhage (3.45 [1.16,
10.26]; P=0.026), but the relationship was not signiﬁcant when index of microvascular resistance (IMR) >40 or change in index of
microvascular resistance (5 per unit) was included. However, a bimodal thermodilution waveform was independently associated with all-
cause death and hospitalization for heart failure (odds ratio [95% conﬁdence interval]=2.70 [1.10, 6.63]; P=0.031), independent of index of
microvascular resistance>40, ST-segment resolution, and TIMI (Thrombolysis in Myocardial Infarction) Myocardial Perfusion Grade.
Conclusions-—The thermodilution waveform in the culprit coronary artery is a biomarker of prognosis and may be useful for risk
stratiﬁcation immediately after reperfusion therapy. ( J Am Heart Assoc. 2018;7:e008957. DOI: 10.1161/JAHA.118.008957.)
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P ercutaneous coronary intervention (PCI) for acute ST-elevation myocardial infarction (STEMI) routinely leads to
successful coronary reperfusion.1,2 However, failed myocar-
dial reperfusion, depicted by microvascular obstruction on
contrast-enhanced cardiac magnetic resonance (CMR)
imaging, occurs in more than half of these patients,3,4
implicating an adverse long-term prognosis.5,6
Microvascular obstruction usually passes undetected in
clinical practice. Standard measures of myocardial reperfu-
sion, including TIMI (Thrombolysis in Myocardial Infarction)
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Myocardial Perfusion Grade and corrected frame count, or ST-
segment resolution on the ECG, lack sensitivity and repro-
ducibility.6-9 CMR is the reference noninvasive technique for
detection of microvascular pathology3,5,10; however, CMR is
neither feasible acutely norwidely available1 and is not routinely
recommended in contemporary practice guidelines.1,11
The index of microvascular resistance (IMR) is a direct
invasive measure of microvascular function that can be per-
formed routinely in the cardiac catheterization laboratory
immediately after revascularization to identify patients
with failed reperfusion. IMR is inversely associated with left
ventricular (LV) function post-MI12 and positively associated
with infarct size12 and pathology.2 An IMR >40 is a multivari-
able associate of mortality post-STEMI.12,13
Because downstream microvascular resistance inﬂuences
coronary blood ﬂow, the characteristics of the thermodilution
waveform in the culprit coronary artery reﬂect microvascular
dysfunction and infarct pathology in patients with acute
STEMI.14 In a study of 88 patients with acute STEMI, a bimodal
thermodilution waveform in the culprit coronary artery was
associated withmicrovascular dysfunction and cardiac death at
6 months after STEMI, in contrast to IMR.14 However, this
analysis had some limitations including a modest sample size,
short duration of follow-up (6 months), and lack of follow-up
imaging. We aimed to further assess the clinical signiﬁcance of
the thermodilution waveform in the culprit coronary artery in a
large and relatively unselected population of STEMI survivors.
Methods
The data, analytic methods, and study materials will be made
available on request to other researchers for purposes of
reproducing the results or replicating the procedure. The
study was approved by the West of Scotland Research Ethics
Committee, reference 10-S0703-28, and informed consent
was obtained from each patient.
Study Population
Between July 14, 2011 and November 22, 2012, 278 STEMI
patientswith acuteSTEMIwhowere reperfusedpredominantlyby
emergency PCI were prospectively enrolled (British Heart Foun-
dation MR-MI; ClinicalTrials.gov: NCT02072850). All patients
gave informed consent to undergo a diagnostic guidewire-based
assessment at the end of the PCI procedure, then CMR 2 days
and 6 months later, and follow-up for health outcomes in the
longer term. Patients with a contraindication to CMR, such as a
pacemaker or severe renal dysfunction, were not enrolled.
Thermodilution in the Culprit Coronary Artery
Thermodilution curves were manually acquired after PCI of the
infarct-related artery using a dual-sensor pressure- and tem-
perature-sensitive coronary guidewire (Abbott Vascular, Santa
Clara, CA). The diagnostic wire was calibrated outside the body,
equalized with aortic pressure at the ostium of the guide
catheter, and then advanced to the distal third of the culprit
artery. We used guide catheters without side holes to allow
delivery of a saline bolus into the coronary ostium. Care was
also taken to ensure that the guide catheter was properly
intubated and that the catheter was ﬂushed with saline,
thereby removing contrast medium that could potentially
interfere with the measurements. The injections were pre-
ceded by a 2-mL bolus of 200 lg of nitrate.
Thermodilution curves in the culprit coronary artery were
obtained by repeated manual injections of 3 mL of room-
temperature saline during maximal hyperemia induced by
continuous intravenous infusion of adenosine (140 lg/
[kgmin]). The average of the 3 values was taken as the mean
hyperemic transit time. Following injection of the saline bolus
into the coronary artery, the reduction in temperature of the
coronary blood was detected by the thermistor at the distal end
of the guidewire. The thermodilution curve (time [seconds] on x-
axis, temperature on y-axis) was recorded in real time
(RADIAnalyzer, Abbott Vascular, Santa Clara, CA) and available
for analysis (Radiview 2.2, St Jude Medical, St. Paul, MN). IMR
was calculated as the product of simultaneously measured
Clinical Perspective
What Is New?
• In acute ST-segment–elevation myocardial infarction sur-
vivors, coronary thermodilution waveforms depicted using a
diagnostic guidewire at the end of percutaneous coronary
intervention provides information that is linked with
microvascular injury.
• A bimodal thermodilution waveform is independently asso-
ciated with adverse clinical outcomes, including all-cause
death and heart failure in the longer term.
• A bimodal thermodilution waveform is a biomarker for
prognostication in survivors of acute ST-segment–elevation
myocardial infarction.
What Are the Clinical Implications?
• Risk assessment of failed reperfusion in patients undergoing
emergency percutaneous coronary intervention for acute
ST-segment–elevation myocardial infarction is challenging.
• Use of a diagnostic guidewire at the end of the percuta-
neous coronary intervention has emerging clinical utility for
risk assessment.
• Classiﬁcation of the coronary thermodilution waveform
categorization is a novel approach to identify at-risk
subgroups that has the potential to translate into real-world
practice merits assessment.
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distal coronary pressure (mm Hg) and mean hyperemic transit
time (seconds), as previously described.12,13
Assessment of Coronary Thermodilution
Waveforms
Thermodilution waveforms were analyzed by a trained observer
(S.N.Y.) who was blind to all of the magnetic resonance imaging
(MRI) and clinical data. S.N.Y was trained and supported by D.C.
and C.B. The waveforms were classiﬁed into 3 groups according
to the shape of the thermodilution curve: sharp unimodal, wide
unimodal, and bimodal (Figure 1). The mean transit time from
the start of the thermodilution curve (reduction in temperature)
to the maximum reduction in temperature of all the unimodal
thermodilution curves was measured (mean [SD]=0.42 [0.15]
seconds). A narrow unimodal waveformwas deﬁned as an acute
temperature reduction followed by rapid return to the resting
temperature, with a time from the beginning of the reduction to
the minimum temperature (trough) of less than 0.42 seconds. A
wide unimodal waveformwas deﬁned as a temperature decrease
to a nadir followed by gradual return to the baseline temperature
with a time from the inﬂection of the curve to the minimum
temperature of more than 0.42 seconds. A bimodal waveform
was deﬁned as a waveform with 2 distinct nadirs (deﬁned as the
secondnadir being lower than20%of thepeak temperature drop).
Intra- and interobserver (S.N.Y. and D.C.) variabilities were
assessed. Following completion of these analyses, the database
was then closed before associationwith theMRI and clinical data.
Cardiac MRI Protocol
CMR was performed on a Siemens MAGNETOM Avanto (Erlan-
gen, Germany) 1.5-Tesla scanner with a 12-element phased-
array cardiac surface soil15 on day 2 and 6 months after
reperfusion. CMR provided the reference data on LV function,
pathology, and surrogate outcomes independent of the invasive
tests. The images were analyzed by observers with at least
3 years of CMR experience (N.A., D.C., I.M.) and were reviewed
by an experienced cardiologist (C.B.). The CMR images were
assessed independently of the coronary thermodilution data.
Infarct Size, Microvascular Obstruction, and
Myocardial Hemorrhage
The presence of acute infarction was established based on
abnormalities in cine wall motion, rest ﬁrst-pass myocardial
perfusion, and delayed-enhancement imaging in 2 imaging
planes.16 Microvascular obstruction was deﬁned as a dark zone
on early gadolinium enhancement imaging 1, 3, and 5 minutes
postcontrast injection that remained present within an area of
late gadolinium enhancement at 15 minutes. On the T2* CMR
maps, a region of reduced signal intensity within the infarcted
area, with a T2* value of <20 milliseconds17-20 was considered
to conﬁrm the presence of myocardial hemorrhage.
Myocardial Edema and Salvage
The extent of myocardial edema was deﬁned as LVmyocardium
with pixel values (T2) >2 standard deviations from remote
myocardium.21-26 Myocardial salvage was calculated by sub-
traction of percentage infarct size from percentage area at risk,
as reﬂected by the extent of edema.23,26,27 The myocardial
salvage index was calculated by dividing themyocardial salvage
area by the initial area at risk.
ECG Analysis
A 12-lead ECG was obtained before coronary reperfusion and
60 minutes afterwards. The extent of ST-segment resolution on
theECGassessed60 minutesafter reperfusioncompared to the
baseline ECG before reperfusion28 was expressed as complete
(≥70%), incomplete (30% to <70%), or none (≤30%).
Coronary Angiogram Acquisition and Analyses
Coronary angiograms were acquired during usual care with
cardiac catheter laboratory x-ray (Innova; GE Healthcare,
Chicago, IL) and information technology equipment (Centricity; GE
Healthcare).Theangiogramswereanalyzedbytrainedobservers(J.C.,
V.T.Y.M.)whowereblinded toall otherclinical andMRIdata. TheTIMI
coronary ﬂow grade29 and frame count30 were assessed at initial
angiography and at the end of the procedure. TIMI myocardial
perfusiongrade31wasassessedattheendoftheprocedure(DataS1).
Laboratory Analyses
The acquisition of blood samples for biochemical and
hematologic analyses is described in Data S1.
Predeﬁned Health Outcomes
We predeﬁned adverse health outcomes that are pathophysio-
logically linked with the natural history of myocardial infarction
andLVremodeling.31,32Theprimarycompositeoutcomewasall-
cause death or a ﬁrst heart failure event following the initial
hospitalization (Data S1). These outcomes were independently
assessed by a cardiologist whowas blinded to the baseline data.
Statistical Analyses
Continuous variables were presented as means with standard
deviation if they were normally distributed. If not, they were
presented as medians with interquartile range. Differences in
continuous variables between groups were assessed by the
Student t test or ANOVA if the data were normally distributed
or by the nonparametric Mann-Whitney test or Kruskal-Wallis
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test if the data were not normally distributed. Categorical
variables are expressed as the number and percentage of
patients. Differences in categorical variables between groups
were assessed using a Fisher test.
Twenty subjects were randomly selected from the 278
patients, and the thermodilution pattern of these 20 subjects
was analyzed repeatedly. The interobserver (D.C. and S.N.Y.)
and intraobserver reliability for the visual assessment of
thermodilution waveforms was assessed using weighted Cohen
j. Univariable and multivariable associations were assessed
using binary logistic regression or linear regression. Logistic
regression was used to identify potential clinical predictors of
all-cause death or heart failure hospitalization, including patient
characteristics, CMR ﬁndings, IMR, and thermodilution wave-
form pattern. The Akaike information criterion was used to
assess the relative quality of the statistical models. All P-values
are 2-sided, and a P-value of more than 0.05 indicates the
absence of statistically signiﬁcant effect. Statistical analyses
were performed using SPSS version 22 (IBM, Armonk, NY).
Results
Patient Characteristics
A total of 278 patients had thermodilution performed in the
culprit coronary artery (Table 1; Figure 2). Of these, 143 (51%)
had a narrowunimodal waveform, 100 (36%) patients had awide
unimodal waveform, and 35 (13%) patients had a bimodal
waveform. Representative cases are illustrated in Figure 1. The
intraobserver variability and interobserver variability were
j=0.740 and 0.706, respectively.
The patients with a bimodal coronary thermodilution mor-
phology had more adverse clinical characteristics, including an
occluded culprit coronary artery at presentation (P=0.007),
Figure 1. Thermodilutionwaveformsobtained in theculprit coronaryarteryat theendofPCI in3patientswith
acute STEMI. The coronary thermodilution curves are obtained in triplicate at rest (blue) and then again during
hyperemia (orange) induced by intravenous infusion of adenosine (140 lg/[kgmin]). The green-highlighted
curve represents the “live” measurement of interest according to the software settings. A, A patient with a
narrow unimodal waveform and the image obtained using CMR with late gadolinium enhancement (showing a
subendocardial infarct with no microvascular obstruction) 2 days later; (B) a wide unimodal waveform and
a larger area of transmural infarction revealed byCMR; (C) a bimodal waveform in associationwith an extensive
area of infarction complicated by microvascular obstruction (central dark zone within the bright area of
infarction). CMR indicates coronary magnetic resonance imaging; MRI, magnetic resonance imaging; PCI,
percutaneous coronary intervention; STEMI, ST-segment–elevation myocardial infarction.
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Table 1. Characteristics of the Patients Grouped by the Type of Thermodilution Waveform in the Culprit Coronary Artery at the End
of PCI
Characteristics
All Patients
n=278
Narrow Unimodal
n=143 (51%)
Wide Unimodal
n=100 (36%)
Bimodal
n=35 (13%) P Value
Age, y 5911 5811 6111 6212 0.114
Male, n (%) 199 (72) 99 (69) 76 (76) 24 (69) 0.474
BMI, kg/m2 295 295 294 285 0.632
Hypertension, n (%) 87 (31) 45 (32) 28 (28) 14 (40) 0.399
Current smoking, n (%) 175 (63) 95 (66) 59 (59) 21 (60) 0.451
Diabetes mellitus, n (%)* 32 (12) 17 (12) 12 (12) 3 (9) 0.930
Previous myocardial infarction, n (%) 18 (7) 13 (9) 3 (3) 2 (6) 0.154
Previous PCI, n (%) 14 (5) 8 (6) 4 (4) 2 (6) 0.797
Presenting characteristics
Heart rate, bpm 7817 7817 7717 8015 0.575
Systolic blood pressure, mm Hg 13525 13526 13625 13223 0.752
Symptom onset to reperfusion, min 256211 259229 244186 277208 0.731
Killip class, n (%)
I 198 (71) 110 (77) 72 (72) 16 (46) 0.003
II 59 (21) 26 (18) 22 (22) 11 (4)
III/IV 21 (8) 7 (5) 6 (6) 8 (23)
ST-segment resolution post-PCI, n (%)
Complete, ≥70% 126 (46) 67 (47) 48 (48) 11 (31) 0.473
Incomplete, 30% to <70% 113 (41) 57 (40) 18 (51) 38 (38)
None, ≤30% 38 (14) 18 (13) 14 (14) 6 (17)
IMR>40 84 (30) 16 (11) 45 (45) 23 (66) <0.001
Reperfusion strategy, n (%)†
Primary PCI 257 (92) 135 (94) 88 (88) 34 (97) 0.369
Number of diseased arteries, n (%)
1 153 (55) 83 (58) 50 (50) 20 (57) 0.475
2 85 (31) 45 (32) 30 (30) 10 (29)
3 36 (13) 14 (10) 17 (17) 5 (14)
Left main 4 (1) 1 (1) 3 (3) 0 (0)
Culprit artery, n (%)
Left anterior descending 101 (36) 55 (39) 31 (31) 15 (43) 0.418
Left circumflex 52 (19) 30 (21) 17 (17) 5 (14)
Right coronary 125 (45) 58 (41) 52 (52) 15 (43)
Culprit artery TIMI flow grade at initial angiography, n (%)
0/1 204 (73) 93 (65) 79 (79) 32 (91) 0.007
2 48 (17) 33 (23) 12 (12) 3 (9)
3 26 (9) 17 (12) 9 (9) 0 (0)
Culprit artery TIMI flow grade post-PCI, n (%)
0/1 1 (0) 1 (1) 0 (0) 0 (0) 0.026
2 12 (4) 5 (4) 2 (2) 5 (14)
3 265 (95) 137 (96) 98 (98) 30 (86)
Continued
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worse ﬂow in the culprit artery at the end of the procedure
(P=0.026), a higher proportion with Killip class III and IV heart
failure (P=0.003), and a higher circulating monocyte count
(P=0.011). A bimodal waveform was also positively associated
with the circulating concentration of NT-proBNP (N-terminal pro
b-type natriuretic peptide) (P=0.006) (Table 1).
Thermodilution Waveforms and IMR
Themedian (interquartile range) IMR of the bimodalmorphology
group was higher than those in the narrow and wide unimodal
groups (narrow unimodal 18 [12-27] units, wide unimodal 36
[21-52] units, bimodal 54 [32-101] units, P<0.001). Eighty-four
(30%) patients hadan IMR>40 units. An IMR>40occurred in16
(11%)patients in thenarrowunimodalgroup,45 (45%)patients in
the wide unimodal group, and 23 (66%) patients in the bimodal
waveform group, respectively (P<0.001).
Cardiac Magnetic Resonance Imaging
Thermodilution Waveforms and LV Ejection Fraction
TheCMRﬁndings at baselineand6 monthswere groupedby the
type of culprit artery thermodilution waveform (Table 2). The LV
ejection fractions at baseline (P<0.001) and at follow-up
(P=0.001) were lower in the bimodal group.
Thermodilution Waveforms and Infarct Characteristics
Acute and ﬁnal infarct sizes at 6 months were greatest in
the bimodal waveform group (Table 2). Microvascular
obstruction and myocardial hemorrhage were associated
with thermodilution waveform pattern (P=0.002 and 0.004,
respectively) (Table 3), and proportionately more patients in
the bimodal waveform group were affected (Table 2).
Multivariable Associations of Thermodilution
Waveform Type in the Culprit Coronary Artery
and Microvascular Infarct Pathology
Microvascular Obstruction
In abinary logistic regressionmodelwithbaselinecharacteristics,
thermodilution waveform status was a multivariable associate of
microvascular obstruction revealed by CMR 2 days post–my-
ocardial infarction (Table 4). This relationship was no longer
signiﬁcant when IMR>40 or an IMR (5 per unit) were included.
Myocardial Hemorrhage
Thermodilution waveform status was a multivariable associate
of myocardial hemorrhage (Table 5), but this relationship was
no longer signiﬁcant when an IMR >40 (P>0.05) or an IMR
(per 5 unit) (P>0.05) was included.
Thermodilution Waveforms and LV Outcomes
During Follow-Up
Changes in LV End-Diastolic Volume
IMR (5 unit difference) was a multivariable associate of
change in LV end-diastolic volume, independent of
Table 1. Continued
Characteristics
All Patients
n=278
Narrow Unimodal
n=143 (51%)
Wide Unimodal
n=100 (36%)
Bimodal
n=35 (13%) P Value
TIMI Myocardial Blush Grade
0/1 78 (28) 38 (27) 27 (27) 13 (37) 0.436
2/3 200 (72) 105 (73) 73 (73) 22 (63)
Treatment, n (%)
Aspirin 277 (100) 142 (99) 100 (100) 35 (100) 1.000
Clopidogrel 275 (99) 141 (99) 99 (99) 35 (100) 1.000
b-Blocker 266 (96) 137 (96) 95 (95) 34 (97) 0.861
ACE inhibitor or angiotensin receptor blocker 275 (99) 141 (99) 99 (99) 35 (100) 0.769
Blood results on admission
Troponin I, ng/L, median (Q1-Q3) 1710 (109–5104) 1628 (97–3673) 1762 (111–5245) 2932 (129–7766) 0.159
Monocytes, 9109/L 1.10.4 1.00.3 1.10.4 1.30.4 0.011
NT-proBNP, pg/mL 12991473 9641218 14401535 23441848 0.006
Killip classiﬁcation of heart failure after acute myocardial infarction: class I, no heart failure; class II, pulmonary rales or crepitations, a third heart sound, and elevated jugular venous
pressure; class III, acute pulmonary edema; class IV, cardiogenic shock. ACE indicates angiotensin converting enzyme; BMI, body mass index; IMR, index of microvascular resistance; IQR,
interquartile range; NT-proBNP, N-terminal pro b-type natriuretic peptide; PCI, percutaneous coronary intervention; TIMI, Thrombolysis in Myocardial Infarction grade.
*Data are reported as mean (SD), median (IQR), or N (%) as appropriate. P values have been obtained from a t test (t), Mann-Whitney test, or Fisher test.
†Reperfusion strategy includes primary PCI (n=257 [92%]), rescue PCI (failed thrombolysis; n=14 [5%]), and successful thrombolysis (n=7 [3%]). A diseased artery is deﬁned as a stenosis
>50% in a major coronary artery >2.5 mm in diameter.
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thermodilution waveform status (regression coefﬁcient [95%
conﬁdence interval]=0.87 [0.11, 1.62], P=0.024) (Table S1).
Changes in LV Ejection Fraction
Thermodilution waveform status, IMR>40, and IMR (for a 5-
unit change) were not associates of changes in LV ejection
fraction (Table S2).
Thermodilution Waveforms and Longer-Term
Health Outcomes
All-Cause Death or Heart Failure Hospitalization
The median duration of follow-up was 1469 days in 278 STEMI
patients. During this time, 40 (14.4%) participants died or
experienced a heart failure episode. The occurrence of a
Acute STEMI patients 
assessed for eligibility 
(n = 288)
No CMR at 6 months follow-up (n = 21)
● Death (n = 3)
● Refusal (n = 15)
● Unable to contact (n = 1)
● Did not attend (n = 2)
Analysis
Follow-Up
Enrollment with 
informed consent
CMR 6 months post-STEMI (n = 257)
CMR with T2* map at follow up (n = 219)
Health Outcomes in longer term (n = 278)
No CMR = (5)
● Claustrophobia (n=4)
● Contraindication to MRI (n=1) 
No thermodilution waveforms = (5)
● Operator did not acquire 
thermodilution waveforms 
Pressure wire assessment with
thermodilution waveform (n = 278)
CMR with analyzed thermodilution
waveform (n = 278) 
CMR with evaluable T2* map
(n = 217)
T2* maps non-evaluable due to severe 
motion artefact (n = 32)
CMR performed but T2* map not acquired 
(n = 29)
Figure 2. CONSORT (Consolidated Standards of Reporting Trials) ﬂow diagram of the study. CMR
indicates cardiac magnetic resonance; STEMI, ST-segment–elevation myocardial infarction.
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bimodal thermodilution waveform was independently associ-
ated with all-cause death and heart failure hospitalization (odds
ratio [95% conﬁdence interval]=2.70 [1.10, 6.63]; P=0.031),
independent of IMR>40, ST-segment resolution, and TIMI
Myocardial Perfusion grade (Table 6). However, the relation-
ship was not statistically signiﬁcant (odds ratio [95% conﬁdence
interval]=2.35 [0.90, 6.14]; P=0.080) when infarct size was
included in the model (Table 6).
Nineteen (6.8%) patients died during follow-up. IMR alone
was not associated with death (Table 6).
Discussion
The main ﬁndings of our study are these: (1) thermodilution in
the culprit coronary artery was straightforward and feasible to
perform in a comparatively large number of patients with
Table 2. CMR Findings at Baseline and at 6 Months in STEMI Patients Grouped by Thermodilution Waveforms Post-PCI
Characteristics* All Patients (n=278)
Thermodilution Waveform
P Value
Narrow
Unimodal (n=143)
Wide Unimodal
(n=100) Bimodal (n=35)
CMR findings 2 d post-MI
LV ejection fraction, % 5510 578 5510 4912 <0.001
LV end-diastolic volume, mL
Men 16032 15632 16434 16625 0.204
Women 12524 12825 12328 12127 0.902
LV end-systolic volume, mL
Men 7426 6922 7729 8825 0.003
Women 5517 5417 5318 6119 0.437
LV mass, g
Men 14433 14433 14436 14219 0.965
Women 9922 9714 10230 10127 0.682
Edema and infarct characteristics
Myocardial edema, % LV mass 3212 3011 3311 3613 0.009
Infarct size, % LV mass 1813 1613 1814 2515 0.003
Myocardial salvage, % LV mass 199 199 198.3 199 0.881
Myocardial salvage index, % LV mass 6324 6524 6123 5624 0.115
Microvascular obstruction present, n (%) 162 (58) 75 (52) 58 (58) 29 (83) 0.005
Microvascular obstruction, % LV mass 35 24 35 68 <0.001
Presence of myocardial hemorrhage 90 (42) 40 (35) 32 (42) 18 (67) 0.011
Myocardial hemorrhage, % LV mass 8.36.2 8.16.7 7.05.8 11.25.1 0.070
CMR findings 6 mo post-MI (n=257)
LV ejection fraction at 6 mo, % 6210 649 629 5712 0.001
LV end-diastolic volume at
6 mo, mL
Men 16742 16136 17147 18647 0.035
Women 12729 12825 12837 12127 0.799
LV end-systolic volume at 6 mo, mL
Men 6735 6124 6940 8847 0.004
Women 4617 4619 4413 4920 0.721
Infarct size at 6 mo
Infarct size, % LV mass 1310 119 1310 1712 0.004
Data are given as n (%) or mean (SD). P-values were obtained from a t test (t), a Mann-Whitney test, or a Fisher test. CMR indicates cardiac magnetic resonance imaging; IQR,
interquartile range; LV, left ventricle; MI, myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-segment–elevation myocardial infarction.
*Data are reported as mean (SD), median (IQR), or n (%) as appropriate.
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acute STEMI, and intraobserver and interobserver variabilities
for classiﬁcation of the waveform morphologies were reason-
ably high; (2) thermodilution waveform type was associated
with IMR. A bimodal waveform was a multivariable associate
of microvascular obstruction; however, this relationship was
no longer signiﬁcant when IMR was included (either IMR [for a
5-unit change] or IMR>40); (3) IMR (for a 5-unit change) was
an independent predictor of myocardial hemorrhage; (4) a
bimodal thermodilution waveform was a multivariable associ-
ate of adverse clinical outcomes during follow-up, including
after adjustment for IMR>40.
Taken together, these results indicate that a bimodal
waveform is an associate of adverse clinical outcomes post–
myocardial,infarction and may be useful for risk stratiﬁcation
of STEMI patients immediately after reperfusion therapy.
Waveform classiﬁcation and IMR have relative merits. The
waveform classiﬁcation represents a binary approach to risk
stratiﬁcation, whereas IMR and other indices (such as
hyperemic microvascular resistance derived using Doppler)
provide a continuous measure of microvascular dysfunction
and in this sense may be more informative.
Fearon et al ﬁrst reported that an IMR>40 measured after
angiographically successful primary PCI was an independent
predictor of adverse clinical outcome.12 We previously found
Table 3. Univariable Association Among Thermodilution Waveform, IMR (for a 5-Unit Change), and LV Function and Pathology
Revealed on CMR
Left Ventricular Function and
Pathology Revealed on CMR
Microvascular
Obstruction
Intramyocardial
Hemorrhage
Infarct Size During
Follow-Up at 6 Months Change in LV Ejection Fraction
Change in LV End-Diastolic
Volume
OR (95% CI)
P Value
OR (95% CI)
P Value
Coefﬁcient (95% CI)
P Value
Coefﬁcient (95% CI)
P Value
Coefﬁcient (95% CI)
P Value
IMR (for a 5-unit change) 1.12 (1.06, 1.18)
<0.001
1.11 (1.05, 1.17)
<0.001
0.63 (0.44, 0.82)
<0.001
6.78 (5.33, 8.24)
<0.001
0.85 (0.31, 1.40)
0.002
IMR>40 (yes vs no) 2.28 (1.34, 3.89)
0.002
2.26 (1.24, 4.05)
0.006
1.56 (0.24, 2.88)
0.020
1.83 (3.80, 0.14)
0.068
9.97 (2.88, 17.07)
0.006
Thermodilution waveform (reference=narrow unimodal)
Wide unimodal 1.25 (0.75, 2.10)
0.392
1.35 (0.74, 2.44)
0.392
2.24 (0.37, 4.86)
0.092
0.18 (2.26, 1.91)
0.869
4.64 (2.44, 11.72)
0.198
Bimodal 4.38 (1.72, 11.20)
0.002
3.70 (1.52, 8.99)
0.004
6.38 (2.54, 10.22)
0.001
0.50 (3.60, 2.59)
0.749
7.69 (2.81, 18.18)
0.769
IMR >40 and bimodal 2.44 (2.63, 49.84)
0.001
1.50 (1.56, 12.98)
0.005
1.15 (1.07, 3.38)
0.309
4.97 (8.31, 1.64)
0.004
7.37 (5.07, 19.81)
0.244
CI indicates conﬁdence interval; CMR, cardiac magnetic resonance imaging; IMR, index of microvascular resistance; LV, left ventricle; OR, odds ratio.
Table 4. Multivariable Associations Between Clinical
Characteristics at Presentation, Including Thermodilution
Waveforms, and the Occurrence of Microvascular Obstruction
2 Days Later in Patients With Acute STEMI
Binary Logistic Regression Odds Ratio (95% CI) P Value
Bimodal waveform 5.29 (1.73, 16.22) 0.004
ST-segment resolution
None 2.44 (1.30, 4.57) 0.006
Partial 3.54 (1.34, 9.33) 0.011
Sex 2.17 (1.13, 4.16) 0.020
Previous PCI 10.97 (1.03, 116.83) 0.047
Other baseline characteristics included are smokers (P=0.114), hypertension (P=0.155),
wide unimodal waveform (P=0.388), hypercholesterolemia (P=0.390), previous angina
(P=0.405), age, y (P=0.599), TIMI Myocardial Perfusion Grade post-PCI 2/3 (P=0.60),
BMI, kg/m2 (P=0.615), SBP per 10 mm Hg (P=0.685), previous MI (P=0.776), heart rate,
bpm (P=0.819), diabetes mellitus (P=0.980), symptoms to reperfusion time per
10 minutes (P=0.084). BMI indicates body mass index; CI, conﬁdence interval; MI,
myocardial infarction; PCI, percutaneous coronary intervention; SBP, systolic blood
pressure; STEMI, ST-segment–elevation myocardial infarction; TIMI, Thrombolysis in
Myocardial Infarction.
Table 5. Multivariable Associations Between Clinical
Characteristics at Presentation, Including Thermodilution
Waveform, and the Occurrence of Myocardial Hemorrhage
2 Days Later in Patients With Acute STEMI
Binary Logistic Regression Odds Ratio (95% CI) P Value
Smoker 3.93 (1.70, 8.65) 0.001
ST-segment resolution—partial 3.88 (1.36, 11.09) 0.012
Sex 2.65 (1.20, 5.85) 0.016
Bimodal waveform 3.45 (1.16, 10.26) 0.026
Other baseline characteristics included are ST-segment resolution—none (P=0.066),
previous PCI (P=0.086), symptoms to reperfusion time per 10 minutes (P=0.171), wide
unimodal waveform (P=0.171), age, y (P=0.218), hypercholesterolemia (P=0.254), heart
rate, bpm (P=0.545), previous MI (P=0.556), hypertension (P=0.573), systolic blood
pressure per 10 mm Hg (P=0.582), percentage residual stenosis (P=0.773), BMI
(P=0.860), diabetes mellitus (P=0.861), previous angina (P=0.870), TIMI Myocardial
Perfusion Grade post-PCI 2/3 (P=0.976). BMI indicates body mass index; CI, conﬁdence
interval; MI, myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-
segment–elevation myocardial infarction; TIMI, Thrombolysis in Myocardial Infarction.
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that an IMR value of >27 was most closely associated with
microvascular obstruction and myocardial hemorrhage,
whereas an IMR >40 was most closely associated with all-
cause death or heart failure.13 We also observed that IMR was
Table 6. Association Between Clinical Factors at the Time of
Invasive Management, Including the Type of Coronary
Thermodilution Waveform, and All-Cause Death or Heart
Failure Hospitalization and Death Only After the Index
Admission During Longer-Term Follow-Up in 278 STEMI
Patients
Associations Odd Ratio (95% CI) P Value
Univariable associations with all-cause death or heart failure
Bimodal waveform 4.01 (1.80, 8.93) 0.001
IMR>40 and bimodal waveform 5.77 (2.33, 14.31) <0.001
IMR>40 2.41 (1.22, 4.77) 0.012
IMR (for a 5-unit change) 1.07 (1.02, 1.12) 0.003
TIMI Myocardial Perfusion
Grade 2/3
1.67 (0.83, 3.36) 0.154
ST-segment resolution<50% 2.52 (1.23, 5.17) 0.011
Acute infarct size 1.09 (1.06, 1.12) <0.001
Multivariable associations with all-cause death or heart failure
Model A—bimodal waveform and IMR
Bimodal waveform 2.46 (0.95, 6.40) 0.065
IMR (for a 5-unit change) 1.04 (0.99, 1.10) 0.144
ST-segment resolution<50% 1.92 (0.90, 4.10) 0.093
TIMI Myocardial Perfusion
Grade 2/3
1.28 (0.58, 2.85) 0.545
Akaike Information Criterion 131.84
Model B—bimodal waveform and IMR>40
Bimodal waveform 2.70 (1.10, 6.63) 0.031
IMR>40 1.84 (0.84, 4.03) 0.128
ST-segment resolution<50% 1.92 (0.90, 4.10) 0.092
TIMI Myocardial Perfusion
Grade 2/3
1.32 (0.60, 2.90) 0.487
Akaike Information Criterion 51.60
Model C—bimodal waveform only
Bimodal waveform 3.32 (1.41, 7.82) 0.006
ST-segment resolution<50% 2.01 (0.94, 4.26) 0.329
TIMI Myocardial Perfusion
grade 2/3
1.47 (0.68, 3.16) 0.070
Akaike Information Criterion 33.28
Model D—IMR (for a 5-unit change) only
IMR (for a 5-unit change) 1.07 (1.01, 1.12) 0.014
ST-segment resolution <50% 2.08 (0.99, 4.38) 0.054
TIMI Myocardial Perfusion
Grade 2/3
1.27 (0.58, 2.78) 0.558
Akaike Information Criterion 199.91
Model E—IMR>40 only
IMR>40 2.29 (1.09, 4.81) 0.028
ST-segment resolution <50% 2.14 (1.02, 4.49) 0.043
Continued
Table 6. Continued
Associations Odd Ratio (95% CI) P Value
TIMI Myocardial Perfusion
Grade 2/3
1.36 (0.63, 2.93) 0.435
Akaike Information Criterion 34.92
Model F—IMR>40 with bimodal waveform only
IMR>40 and bimodal waveform 4.47 (1.68, 11.89) 0.003
ST-segment resolution<50% 2.02 (0.95, 4.31) 0.068
TIMI Myocardial Perfusion
grade 2/3
1.34 (0.61, 2.93) 0.468
Akaike Information Criterion 32.16
Model G—Bimodal waveform and acute infarct size
Bimodal waveform 2.35 (0.90, 6.14) 0.080
Acute infarct size 1.08 (1.04, 1.11) <0.001
ST-segment resolution<50% 1.24 (0.54, 2.89) 0.611
TIMI Myocardial Perfusion
Grade 2/3
1.27 (0.55, 2.92) 0.577
Akaike Information Criterion 181.66
Model H—IMR (for a 5-unit change) and infarct size
IMR (for a 5-unit change) 1.02 (0.96, 1.08) 0.563
Acute infarct size 1.08 (1.04, 1.11) <0.001
ST-segment resolution<50% 1.41 (0.63, 3.18) 0.405
TIMI Myocardial Perfusion
Grade 2/3
1.26 (0.53, 2.95) 0.602
Akaike Information Criterion 182.85
Model I—IMR>40 with bimodal waveform and infarct size
IMR>40 and bimodal waveform 2.65 (0.91, 7.74) 0.074
Acute infarct size 1.08 (1.04, 1.11) <0.001
ST-segment resolution<50% 1.31 (0.57, 3.00) 0.525
TIMI Myocardial Perfusion
Grade 2/3
1.21 (0.52, 2.82) 0.655
Akaike Information Criterion 177.15
Univariable associations with all-cause death only
Acute infarct size 1.04 (1.01, 1.08) 0.009
Bimodal waveform 1.33 (0.37, 4.82) 0.664
IMR >40 1.07 (0.39, 2.92) 0.893
IMR (for a 5-unit change) 0.99 (0.92, 1.08) 0.890
IMR>40 and bimodal waveform 1.33 (0.29, 6.17) 0.713
Median duration of follow-up was 4 years. Minimum to maximum postdischarge censor
duration was 1 to 1800 days.
All-cause death or heart failure occurred in 40 (14.4%) patients. Death occurred in 19
(6.8%) patients. Logistic regression was used to explore the associations. CI indicates
conﬁdence interval; IMR, index of microvascular resistance; STEMI, ST-segment–
elevation myocardial infarction; TIMI, Thrombolysis in Myocardial Infarction.
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associated with the systemic concentration of IL-6 on the ﬁrst
day post-STEMI, reﬂecting systemic inﬂammation and vascu-
lar injury.13 The current study extends these ﬁndings because
a bimodal thermodilution waveform was associated with heart
failure post–myocardial infarction, systemic inﬂammation
(monocyte count), and circulating concentrations of NT-
proBNP early post–myocardial infarction.
Fukunaga et al14 reported that a bimodal thermodilution
waveform was independently associated with the presence of
microvascular obstruction on CMR, and this was associated
with worse midterm clinical outcomes. They hypothesized that
the bimodal thermodilution waveform may be explained by
resistance to antegrade ﬂow within the culprit coronary artery
due to microvascular destruction.14 IMR derived from a
bimodal curve incorporates a mean transit time derived from
disordered antegrade coronary ﬂow, potentially even transient
retrograde ﬂow, secondary to microvascular dysfunction.33
This scenario calls into question the validity of transit time as
a proxy for ﬂow when the thermodilution curve is bimodal. On
the other hand, the prognostic associations for IMR in
continuous and binary forms are well established. Our
observations are in keeping with those of Fukunaga et al14
and suggest that the bimodal thermodilution waveform
reﬂects more severe, persistent microvascular injury and
has the potential for immediate risk stratiﬁcation in the
catheterization laboratory. Patients with a bimodal waveform
are at risk of adverse outcomes, indicating the need for more
intensive therapy and follow-up.
In our study, microvascular obstruction and myocardial
hemorrhage were associated with thermodilution waveform
pattern, and each pathology was more prevalent in patients
with a bimodal morphology; however, this relationship was not
independent of other characteristics when assessed in a
multivariable regression model. Instead, our results showed
that IMR (for a 5-unit change) was a stronger associate of
microvascular obstruction and myocardial hemorrhage. Logis-
tic regression analysis showed that bimodal thermodilution
waveform status was a stronger predictor of all-cause death
and heart failure hospitalization than IMR. When infarct size
measured on CMR 2 days later was included, the prognostic
signiﬁcance of IMR was lost. IMR (for a 5-unit change) was the
only independent predictor of infarct size during follow-up on
multivariate analyses (Table S3). The associations among IMR
(ordinal value), thermodilution waveform status (bimodal), and
myocardial hemorrhage, reﬂecting severe irreversible vascular
damage within the infarct zone, provide a pathophysiological
basis for adverse health outcomes in the longer term.
Our study extends that of Fukunaga et al.14 Some of the
differences in the resultsmay relate to differences in the patient
populations, sample size, CMR methods used, and duration of
follow-up. For example, Fukunaga et al14 excluded STEMI
patients presentingwith Killip class III/IV acute heart failure and
left mainstem culprit lesions.14 The only exclusion criterion in
our study was a contraindication to contrast MRI. In addition,
our studywas 3 times larger and had substantially longer follow-
up (median of 1469 days versus 6 months). The intra- and
interobserver coefﬁcients reported in our study are lower than
those reported by Fukunaga et al,14 implying that development
of an automated algorithmmay enhance precision and accuracy
in the clinic.
Similar to IMR (for a 5-unit change), a bimodal thermodi-
lution waveform is a stronger predictor of adverse clinical
outcome than ST-segment resolution on ECG, or angiographic
ﬂow grades and may be useful for risk stratiﬁcation of STEMI
patients immediately after reperfusion. IMR is independently
associated with microvascular obstruction and myocardial
hemorrhage, and because it is a continuous value, it holds the
potential to quantify the efﬁcacy of novel reperfusion therapies
designed to restore microvascular perfusion and limit infarct
size. This possibility is currently being assessed in a random-
ized, controlled phase 2 clinical trial of low-dose alteplase (10
and 20 mg) or placebo directly administered into the culprit
coronary artery after reperfusion but before stenting (T-TIME
ClinicalTrials.gov, Identiﬁer: NCT02257294).
Conclusion
Our study adds to previous investigations using coronary
thermodilution for risk assessment in patients with acute
STEMI. We conclude that a bimodal thermodilution waveform
identiﬁes high-risk patients who may beneﬁt from more
intensive follow-up and medical therapy.
Limitations
Our study took place in a single center, and further research
in other hospitals is warranted. Only 13% of patients had a
bimodal waveform, limiting to some extent its clinical impact.
The waveform classiﬁcation was undertaken post hoc using a
core laboratory approach. The diagnostic accuracy of clini-
cian-reported waveform classiﬁcation during real-world prac-
tice merits further assessment.
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Data S1. 
Supplemental Methods 
Setting and study populations 
STEMI patients 
Screening, enrolment, and data collection were prospectively performed by 
cardiologists in the cardiac catheterization laboratories of the Golden Jubilee National 
Hospital, Glasgow, United Kingdom. This hospital is a regional referral centre for 
primary and rescue percutaneous coronary intervention (PCI). The hospital provides 
clinical services for a population of 2.2 million. A screening log was recorded, 
including patients who did not participate in the cohort study. Patients were invited to 
undergo cardiac magnetic resonance imaging (CMR) 2 days and 6 months after hospital 
admission (1)(2). 
Coronary angiogram acquisition 
Coronary angiograms were acquired during usual care with cardiac catheter laboratory 
X-ray (Innova) and IT equipment (Centricity) made by GE Healthcare.  
Percutaneous coronary intervention 
Consecutive admissions with acute STEMI referred for emergency percutaneous 
coronary intervention (PCI) were screened for the inclusion and exclusion criteria. 
During ambulance transfer to the hospital, the patients received 300 mg of aspirin, 600 
mg of clopidogrel and 5000 IU of unfractionated heparin (3, 4). The initial primary PCI 
procedure was performed using radial artery access. A conventional approach to 
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primary PCI was adopted in line with usual care in our hospital (3, 4). Conventional 
bare metal and drug eluting stents were used in line with guideline recommendations 
and clinical judgement. The standard transcatheter approach for reperfusion involves 
minimal intervention with aspiration thrombectomy only or minimal balloon 
angioplasty (e.g. a compliant balloon sized according to the reference vessel diameter 
and inflated at 4-6 atmospheres 1-2 times). During PCI, glycoprotein IIbIIIa inhibitor 
therapy was initiated with high dose tirofiban (25 g/kg/bolus) followed by an 
intravenous infusion of 0.15 g/kg/min for 12 hours, according to clinical judgement 
and indications for bail-out therapy (3, 4). No reflow was treated according to 
contemporary standards of care with intra-coronary nitrate (i.e. 200 g) and adenosine 
(i.e. 30 – 60 g) (3, 4), as clinically appropriate. In patients with multivessel coronary 
disease, multivessel PCI was not recommended, in line with clinical guidelines (3, 4). 
The subsequent management of these patients was symptom-guided. 
Measurement of IMR and CFR at the end of PCI 
We adopted a thermodilution technique rather than Doppler, in order to implement a 
method that is potentially transferable to routine clinical practice. The Doppler 
measurements are more time-consuming, require considerable experience, may be less 
reproducible (5)and the guidewire is typically more expensive. The Doppler method 
less transferrable to every-day practice than the thermodilution method. 
A coronary pressure- and temperature-sensitive guidewire (St Jude Medical, Uppsala, 
Sweden) was used to measure coronary flow reserve (CFR) and the index of 
microvascular resistance (IMR) in the culprit coronary artery at the end of primary or 
rescue PCI. The guidewire was calibrated outside the body, equalized with aortic 
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pressure at the ostium of the guide catheter and then advanced to the distal third of the 
culprit artery. Coronary flow reserve is defined as the mean transit time at rest divided 
by the mean transit time during hyperemia.  
IMR is defined as the distal coronary pressure multiplied by the mean transit time of a 
3 ml bolus of saline at room temperature during maximal coronary hyperemia, 
measured simultaneously (mmHg x s, or units) (6-8).  
Hyperemia was induced by 140 /kg/min of intravenous adenosine preceded by a 2 ml 
intracoronary bolus of 200 µg of nitrate. The mean aortic and distal coronary pressures 
were recorded during maximal hyperemia. We have previously assessed the 
repeatability of IMR using duplicate measurements 5 minutes apart in a subset of 12 
consecutive patients (8). 
 
Visual assessment of coronary thermodilution waveforms 
 
When 3ml of room temperature saline was pushed in the hyperaemic coronary artery, 
the temperature inside the coronary artery dropped, and the change in temperature was 
detected by the thermistor at the end of the guidewire and recorded on Radiview 2.2 
software in a computer in the form of a graph (change in temperature against time). 3 
bolus of 3ml saline were used, producing 3 curves known as the thermodilution curves 
on the graph. We carried out the visual assessment of the coronary blood flow pattern 
of the thermodilution curve using similar method described in Fukunaga et al. 
Fukunaga et’s paper (9). The thermodilution waveforms were classified into 3 groups: 
bimodal, sharp unimodal, and wide unimodal. All bimodal waveforms were identified. 
The transit times from the beginning of drop to the peak drop in temperature of all the 
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unimodal curves are measured, and the mean was calculated (0.42±0.15s). Narrow 
unimodal profile has a transit time less than the mean (0.42s) and wide unimodal profile 
has a transit time more than the mean (0.42s). Narrow unimodal waveform was defined 
as: Sharp decrease of temperature, followed by rapid return to baseline temperature 
with a time from the beginning of drop to the peak drop in temperature is less than 
0.42s. Wide Unimodal waveform was defined as: Decrease of temperature at the 
beginning, followed by gradual return to the baseline temperature. Time from 
beginning of drop to peak drop in temperature is more than 0.42s. Bimodal waveform 
was defined as: waveform with two distinct nadirs (defined as the second nadir having 
a valley deeper than 20% of the peak temperature drop. 
 
Angiographic analysis 
Coronary artery anatomy 
 
The coronary anatomy and disease characteristics of the study participants were 
described based on the clinical reports of the attending cardiologist. Coronary 
dominance were assigned as left, right or balanced according to the origin of the 
posterior descending coronary artery.  
Coronary artery disease severity 
 
Quantitative coronary analysis (QCA) of the culprit vessel was performed by two 
trained observers (J.C., V.Y.T.M) using standard methods (Centricity, GE 
Healthcare, Pollards Wood, UK).  All coronary angiograms were analysed on a single 
image analysis software platform using de-identified images. Automatic edge detection 
algorithms were used to determine the vessel contours by assessing brightness along 
scan lines perpendicular to the vessel center.  Image analysis was performed by two 
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experienced observers supervised by an expert physician, all of whom were blinded to 
the other study data. End-diastolic frames were used to assess disease severity using 
angulations reveal the stenosis at its most severe degree with minimal foreshortening 
and branch overlap.  The coronary artery segments in the culprit artery included all 
those with a reference diameter 1.5 mm.  
Definitions 
TIMI flow grade 
 
Coronary blood flow can be described based on the visual assessment of coronary blood 
flow revealed by contrast injection into the coronary arteries (3, 4, 10).  
TIMI Coronary Flow Grade  
0 No flow 
1 Minimal flow past obstruction 
2 Slow (but complete) filling and slow clearance 
3 Normal flow and clearance 
Myocardial perfusion 
Angiographic evidence of myocardial perfusion will be evaluated using the TIMI 
myocardial perfusion grade (TMP) at the end of the PCI procedure (11).  
Grade  
0 No myocardial blush 
1 Minimal blush and very slow clearing (e.g. present at 
beginning of next cine) 
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2 Good blush with slow clearing of myocardial contrast 
(present at end of cine but gone at beginning of next) 
3 Good blush and normal clearing (ie. gone by end of cine) 
 
Assessment by corrected Thrombolysis In Myocardial Infarction Frame Count 
Corrected TIMI frame count (cTFC) was calculated as the number of frames for dye to 
reach a standardised distal landmark in each angiographic territory. The first frame 
taken for the measurement was the frame in which dye touched both borders of the 
coronary artery in question and moved forward with at least 70% of the vessel lumen 
opacified. The standardised distal landmarks were taken as the first branch of the 
postero-lateral artery for the right coronary artery, the most distal branch of the obtuse 
marginal for the circumflex, and the distal bifurcation of the left anterior descending 
(LAD) coronary artery. The number of frames from the first frame to the last frame 
when the dye entered the standardised distal landmark was counted. A standard image 
acquisition speed of 30 frames per second was used. The correction factor used to 
account for the increased length of the LAD compared to the right and circumflex 
arteries was 1.7 thereby giving a “corrected TIMI frame count”. 
CMR acquisition and analyses 
We used CMR to provide reference data on LV function, pathology and surrogate 
outcomes, independent of the invasive tests.  
CMR acquisition 
CMR was performed on a Siemens MAGNETOM Avanto (Erlangen, Germany) 1.5-
Tesla scanner with a 12-element phased array cardiac surface coil. T2 maps were 
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acquired in contiguous short axis slices covering the whole ventricle, using an 
investigational prototype T2-prepared (T2P) TrueFisp sequence (12, 13). Typical 
imaging parameters were: bandwidth ~947 Hz/pixel; flip angle 70°; T2 preparations: 0 
ms, 24 ms, and 55 ms respectively; matrix 160 x 105 pixels; spatial resolution 2.6 x 2.1 
x 8.0 mm; slice thickness 8 mm. 
T2*-maps were obtained using an investigational prototype T2* map sequence 
acquired in 3 short-axis slices (basal, mid and apical). Typical imaging parameters 
were: bandwidth ~814 (x8) Hz/pixel; flip angle 18°; matrix 256x115; spatial resolution 
2.6 x 1.6 x 10 mm; slice thickness 8 mm. 
In order to assess early microvascular obstruction, early gadolinium enhancement 
imaging was acquired 1, 3, 5 and 7 minutes post-contrast injection using a TrueFISP 
readout and fixed inversion time (TI) of 440 ms. Late gadolinium enhancement images 
covering the entire LV were acquired 10-15 minutes after intravenous injection of 0.15 
mmol/kg of gadoterate meglumine (Gd2+-DOTA, Dotarem, Guebert S.A.) using 
segmented phase-sensitive inversion recovery (PSIR) turbo fast low-angle shot (14). 
Microvascular obstruction was defined as a dark zone on early delayed enhancement 
imaging 1, 3, 5 and 7 minutes post-contrast injection and within an area of late 
gadolinium enhancement. Typical imaging parameters were: matrix = 192 x 256, flip 
angle = 25, TE = 3.36 ms, bandwidth = 130 Hz/pixel, echo spacing = 8.7ms and trigger 
pulse = 2. The voxel size was 1.8 x 1.3 x 8 mm3. Inversion times were individually 
adjusted to optimize nulling of apparently normal myocardium (typical values, 200 to 
300 ms). 
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MR image analyses 
The images were analysed on a Siemens work-station by observers with at least 3 years 
CMR experience (N.A., D.C., I.M). All of the images were reviewed by experienced 
CMR cardiologists (C.B., N.T.). LV dimensions, volumes and ejection fraction were 
quantified using computer assisted planimetry (syngo MR®, Siemens Healthcare, 
Erlangen, Germany). All scan acquisitions were spatially co-registered.  
T2 and T2* – standardized measurements in myocardial regions of interest  
LV contours were delineated with computer assisted planimetry on the raw T2* image 
and the last corresponding T2 raw image, with echo time of 55 ms (15). Contours were 
then copied onto the colour-encoded spatially co-registered maps and corrected when 
necessary by consulting the SSFP cine images. Apical segments were not included 
because of partial volume effects. Particular care was taken to delineate regions of 
interest with adequate margins of separation from tissue interfaces prone to partial 
volume averaging such as between myocardium and blood. Each T2/ T2* map image 
was visually assessed for the presence of artefacts relating to susceptibility effects or 
cardio-respiratory motion. Each map was evaluated against the original images. When 
artefacts occurred, the affected segments were not included in the analysis. 
T2/ T2* values were segmented spatially and regions of interest were defined as (1) 
remote myocardium, (2) injured myocardium and (3) infarct core. The regions-of-
interest were planimetered to include the entire area of interest with distinct margins of 
separation from tissue interfaces to exclude partial volume averaging. The remote 
myocardial region-of-interest was defined as myocardium 180º from the affected zone 
with no visible evidence of infarction, oedema or wall motion abnormalities (assessed 
by inspecting corresponding contrast enhanced T1-weighted, T2-weighted and cine 
images, respectively). The infarct zone region-of-interest was defined as myocardium 
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with pixel values (T2) >2 SD from remote myocardium on T2-weighted CMR (12, 13). 
The infarct core was defined as an area in the center of the infarct territory having a 
mean T2/ T2* value of at least 2 standard deviations (SDs) below the T2/ T2* value of 
the periphery of the area-at-risk.  
In healthy volunteers, the mid-ventricular T2/T2* map was segmented into 6 equal 
segments, using the anterior right ventricular-LV insertion point as the reference point 
(2). T2/T2* was measured in each of these segments, and regions-of-interest were 
planimetered distinct and separate from blood-pool and tissue interfaces. These 
segmental values were also averaged to provide one value per subject. Results are 
presented as average values for segments and slices.   
Infarct definition and size 
The presence of acute infarction was established based on abnormalities in cine wall 
motion, rest first-pass myocardial perfusion, and delayed-enhancement imaging. In 
addition, supporting changes on the ECG and coronary angiogram were also required. 
Acute infarction was considered present only if late gadolinium enhancement was 
confirmed on both the axial and long axis acquisitions. The myocardial mass of late 
gadolinium (grams) was quantified using computer assisted planimetry and the territory 
of infarction was delineated using a signal intensity threshold of >5 standard deviations 
above a remote reference region and expressed as a percentage of total LV mass (5). 
Infarct regions with evidence of microvascular obstruction were included within the 
infarct area and the area of microvascular obstruction was assessed separately and also 
expressed as a percentage of total LV mass. The measurements of infarct size were 
performed by I.M. and N.A. 
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Microvascular obstruction 
Microvascular obstruction was defined as a dark zone on EGE imaging 1, 3, 5 and 7 
minutes post-contrast injection that remained present within an area of late gadolinium 
enhancement at 15 minutes. Identification of microvascular obstruction was performed 
independently by I.M. and N.A. 
Myocardial hemorrhage 
Myocardial haemorrhage was scored visually. On the T2* maps, a region of reduced 
signal intensity within the infarcted area, with a T2* value of <20 ms (16-19), was 
considered to confirm the presence of myocardial haemorrhage. 
Myocardial edema 
The extent of myocardial oedema was defined as LV myocardium with pixel values 
(T1/T2) >2 standard deviations from remote myocardium (12, 13, 20-23).  
Myocardial salvage 
Myocardial salvage was calculated by subtraction of percent infarct size from percent 
area-at-risk (8, 20, 23). The myocardial salvage index was calculated by dividing the 
myocardial salvage area by the initial area-at-risk. 
Adverse remodeling 
Adverse remodelling was defined as an increase in LV end-diastolic volume ≥ 20% at 
6 months from baseline (24). 
Reference ranges 
Reference ranges used in the laboratory were 105 – 215 g for LV mass in men, 70 – 
170 g for LV mass in women, 77 – 195 ml for LV end-diastolic volume in men, 52 – 
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141 ml for LV end-diastolic volume in women, 19 – 72 ml for LV end-systolic volume 
in men and 13 – 51 ml for LV end-systolic volume in women.  
 
Electrocardiogram 
A 12 lead electrocardiogram (ECG) was obtained before coronary reperfusion and 60 
minutes afterwards with Mac-Lab technology (GE Healthcare) in the catheter 
laboratory and a MAC 5500 HD recorder (GE Healthcare) in the Coronary Care Unit. 
The ECGs were acquired by trained cardiology staff. The ECGs were de-identified and 
transferred to the local ECG management system. The ECGs were then analysed by the 
University of Glasgow ECG Core Laboratory which is certified to ISO 9001: 2008 
standards as a UKAS Accredited Organization.  
The extent of ST-segment resolution on the ECG assessed 60 minutes after reperfusion 
compared to the baseline ECG before reperfusion (3) was expressed as complete 
(70%), incomplete (30% to < 70%) or none (30%). ECG evidence of reperfusion 
injury was taken as persistence of ST segment elevation resolution post-procedure, and 
specifically 30% ST-segment resolution post-PCI. 
Biochemical and hematologic measurement of inflammation 
Serial systemic blood sample were obtained immediately after reperfusion in the 
cardiac catheterization laboratory, and subsequently between 0600 - 0700 hrs each day 
during the initial in-patient stay in the Coronary Care Unit. C-reactive protein (CRP) 
was measured in an NHS hospital biochemistry laboratory using a particle enhanced 
immunoturbimetric assay method (Cobras C501, Roche),) and the manufacturers 
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calibrators and quality control material, as a biochemical measure of inflammation. The 
high sensitive assay CRP measuring range is 0.1-250 mg/L. The expected CRP values 
in a healthy adult are < 5 mg/L, and the reference range in our hospital is 0 - 10 mg/L. 
A blood sample was routinely obtained in the cardiac catheter laboratory immediately 
following revascularization and then again at 0700 hrs on the first and second days after 
admission to hospital.  
Haematological measurement of inflammation 
Leucocyte count and leucocyte sub-populations were measured as a hematologic 
measure of inflammation using sheath flow technology incorporating semi-conductor 
laser beam, forward and side scattered light  (Sysmex XT200i and XT1800i for white 
blood cell and differential white blood cell counts, respectively). The linearity ranges 
for white blood cells was 0.00-440.0 x10(9) /L. The following are the normal ranges 
for full blood count parameters: 
 
MALE FEMALE 
WBC x  10^9/L 4.0 - 11.0 4.0 - 11.0 
RBC x 10^12/L 4.50 - 6.50 3.80 - 5.80 
Hgb g/L 130 – 180 115 - 165 
HCT L/L 0.400 - 0.540 0.370 - 0.470 
MCV fL 78 – 99 78 - 99 
MCH Pg 27.0 - 32.0 27.0 - 32.0 
MCHC g/L 310 – 360 310 - 360 
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PLATELETS x 10^9/L 150 – 400 150 - 400 
NEUTROPHILS x 10^9/L 2.5 - 7.5 2.5 - 7.5 
LYMPHOCYTES x 10^9/L 1.5 - 4.0 1.5 - 4.0 
MONOCYTES x 10^9/L 0.2 - 0.8 0.2 - 0.8 
EOSINOPHILS  x 10^9/L 0.0 - 0.4 0.0 - 0.4 
BASOPHILS x 10^9/L 0.01 - 0.10 0.01 - 0.10 
A blood sample was routinely obtained in the cardiac catheter laboratory, immediately 
following revascularization and then again at 0700 on the first and second days after 
admission to hospital.  
Pre-specified health outcomes 
 
We pre-specified adverse health outcomes that are pathophysiologically linked with 
STEMI. The primary composite outcome was (1) all-cause death or first heart failure 
event following the initial hospitalization (Supplementary Methods).  
Research staff screened for events from enrolment by checking the medical 
records and by contacting patients and their primary and secondary care physicians, as 
appropriate with no loss to follow-up (Figure 2). Each serious adverse event (SAE) was 
reviewed by a cardiologist who was independent of the research team and blinded to 
all of the clinical and CMR data. The SAEs were defined according to standard 
guidelines and categorized as having occurred either during the index admission or 
post-discharge. All study participants were followed-up for a minimum of 18 months 
after discharge. The median duration of follow-up was of 1339 days (minimum-
maximum post-discharge censor duration (range) 1-1800 days).  
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Statistics 
Statistical analysis 
 
Categorical variables are expressed as the number and percentage of patients. 
Most continuous variables followed a normal distribution and are therefore presented 
as means together with standard deviation. Those variables that did not follow a normal 
distribution are presented as medians with interquartile range. Differences in 
continuous variables between groups were assessed by the Student’s t-test or ANOVA 
for continuous data with normal distribution, otherwise the nonparametric Mann-
Whitney test or Kruskal-Wallis H test. Differences in categorical variables between 
groups were assessed using a Fisher’s test. 
Two raters assessed the thermodilution waveforms of 20 subjects randomly 
selected from the whole cohort. Inter-rater reliability for the visual assessment of 
thermodilution waveforms was assessed using weighted Cohen’s kappa. 
Univariable and multivariable associations are assessed using binary logistic 
regression or linear regression where appropriate. The likelihood ratio test was used to 
compare the binary logistic and linear regression models with bimodal thermodilution 
waveform, IMR (for a 5 unit change) or an IMR>40. A p-value <0.05 favours including 
the variable in the model. 
All p-values are 2-sided and a p-value > 0.05 indicates the absence of a 
statistically significant effect.  Statistical analyses were performed using SPSS version 
22.  
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Trial Management 
The study was conducted in line with Guidelines for Good Clinical Practice (GCP) in 
Clinical Trials. http://www.mrc.ac.uk/documents/pdf/good-clinical-practice-in-
clinical-trials/  
Trial management included a Trial Management Group, and an independent Clinical 
Trials Unit. Day to day study activity was coordinated by the Trial Management Group 
who was responsible to the Sponsor which was responsible for overall governance and 
that the trial was conducted according to GCP standards.  
Clinical events were assessed and validated by an independent cardiologist (A.M.) who 
had access to relevant source clinical data. This cardiologist followed an agreed charter 
and he was blinded to all of the other clinical data.  
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Table S1. Multivariable associations between clinical characteristics at 
presentation, including thermodilution waveforms, IMR (for a 5 unit change), 
and the change in left ventricular end-diastolic volume at six months in 
patients with acute STEMI.  
Association   Coefficient (95% CI) p value 
LV end-diastolic volume at baseline, ml  -0.05 (-0.18, 0.07) 0.404 
IMR (for a 5 unit change) 0.87 (0.11, 1.62) 0.024 
Diabetes mellitus  -12.17 (-23.48, -0.86) 0.035 
Sex 9.30 (0.29, 18.31)  0.043 
Bimodal waveform -3.44 (-16.60, 9.73) 0.607 
Akaike Information Criterion  1502.39 
 
With waveform only 
  
Diabetes mellitus -12.40 (-23.83, -0.98) 0.033 
Akaike Information Criterion  1506.01 
 
With IMR only 
  
IMR (for a 5 unit change) 0.80 (0.16, 1.45) 0.015 
Sex 9.47 (0.50, 18.43) 0.039 
Diabetes mellitus -11.79 (-23.00, -0.59) 0.039 
Akaike Information Criterion  1498.86 
IMR= index of microvascular resistance. Other variable included are Hypertension 
(P=0.084), Smoker (P=0.169), Hypercholesterolemia (P=0.205), Heart rate, bmp 
(P=0.451), Previous Angina (P=0.489), TIMI blush grade post-PCI 2/3 (P=0.489), Age, 
years (P=0.515), ST segment resolution- none (P=0.521), Percentage Residual 
Stenosis (P=0.652), SBP, per 10mmHg (P=0.680), Previous MI (P=0.737), BMI, kg/m2 
(P=0.815), ST segment resolution- partial (P=0.845), Symptoms to reperfusion time 
per 10 min (P=0.861), Wide unimodal waveform (P=0.884), Previous PCI (P=0.895).   
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Table S2. Multivariable associations between clinical characteristics at 
presentation, including thermodilution waveform, IMR (for a 5 unit change), and 
the change in left ventricular ejection fraction at six months in patients with 
acute STEMI.  
Association  Coefficient (95% CI) p value 
LV ejection fraction at baseline, %  -0.37 (-0.48, -0.26) <0.001 
Previous MI  -6.13 (-10.74, -1.51) 0.01 
TIMI blush grade post-PCI 2/3 2.13 (0.07, 4.19) 0.043 
IMR (for a 5 unit change) -0.12 (-0.32, 0.07) 0.216 
Bimodal waveform -2.07 (-5.43, 1.28) 0.225 
Akaike Information Criterion  880.95 
 
With waveform only 
  
Bimodal waveform -3.04 (-6.03, -0.05) 0.046 
Previous MI -6.29 (-10.90, -1.67) 0.008 
TIMI blush grade post-PCI 2/3 2.44 (0.43, 4.44) 0.018 
LV ejection fraction at baseline, % -0.35 (-0.46, -0.25) <0.001 
Akaike Information Criterion  880.65 
 
With IMR only 
  
IMR (for a 5 unit change) -0.17 (-0.34, -0.01) 0.044 
Previous MI -5.87 (-10.44, -1.30) 0.012 
TIMI blush grade post-PCI 2/3 2.07 (0.03, 4.11) 0.047 
LV ejection fraction at baseline, % -0.36 (-0.47, -0.26) <0.001 
Akaike Information Criterion  878.64 
IMR = index of microvascular resistance, MI= myocardial infarction, TIMI= 
thrombolysis in myocardial infarction. Other variables included are Hypertension 
D
ow
nloaded from
 http://ahajournals.org by on September 10, 2018
(P=0.118), Smoker (P=0.143), Previous PCI (P=0.302), Sex (P=0.312), Age, years 
(P=0.313), Previous angina (P=0.414), Percentage residual stenosis (P=0.420), ST 
segment resolution- None (P=0.485), Hypercholesterolemia (P=0.567), Symptoms to 
reperfusion time per 10 min (P=0.568), ST segment resolution- Partial (P=0.582), 
BMI, kg/m2 (P=0.730), Wide unimodal waveform (P=0.761), Systolic blood pressure 
per 10mmHg (P=0.776), Heart rate, bmp (P=0.817), Diabetes mellitus (P=0.931).  
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Table S3. Multivariable associations between clinical characteristics at 
presentation, including thermodilution waveforms, IMR (for a 5 unit change), 
and infarct size at six months later in patients with acute STEMI.  
Association   Coefficient (95% CI) p value 
Infarct size at baseline, %  0.66 (0.61, 0.71) <0.001 
Previous MI  5.55 (2.32, 8.77) 0.001 
Smoker 1.68 (0.31, 3.05) 0.017 
IMR (for a 5 unit change) 0.14 (0.01, 0.27) 0.031 
TIMI blush grade post-PCI 2/3 -1.26 (-2.64, 0.11) 0.072 
Wide unimodal waveform 1.22 (-0.15, 2.69) 0.079 
Bimodal waveform -0.11 (-2.31, 2.09) 0.922 
Akaike Information Criterion  698.73 
 
With waveform only 
  
Wide unimodal waveform 1.79 (0.51, 3.07) 0.006 
Smoker 1.64 (0.25, 3.02) 0.021 
Previous MI 5.73 (2.48, 8.98) 0.001 
TIMI blush grade post-PCI 2/3 -1.68 (-3.01, -0.34) 0.014 
Infarct size at baseline, % 0.68 (0.63, 0.73) <0.001 
Akaike Information Criterion  701.87 
 
With IMR only 
  
IMR (for a 5 unit change) 0.16 (0.05, 0.27) 0.004 
Smoker 1.64 (0.26, 3.02) 0.020 
Previous MI 5.31 (2.09, 8.52) 0.001 
Infarct size at baseline, % 0.66 (0.61, 0.71) <0.001 
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Akaike Information Criterion  699.05 
 
IMR = index of microvascular resistance, TIMI = thrombolysis in myocardial 
infarction. Other variables included are Previous PCI (P=0.108), Percentage residual 
stenosis (P=0.258), Diabetes mellitus (P=0.399), Previous Angina (P=0.503), 
Hypertension (P=0.511), Sex (P=0.516), ST segment resolution- none (P=0.543), 
Systolic blood pressure per 10mmHg (P=0.565), Heart rate, bmp (P=0.615), Age, 
years (P=0.755), BMI, kg/m2 (P=0.773), Symptoms to reperfusion time per 10 min 
(P=0.792), Hypercholesterolemia (P=0.799), ST segment resolution- partial 
(P=0.913). 
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